The Department of Health (DoH) on Friday demanded a P1.4-billion refund from Sanofi Pasteur for its stock of anti-dengue vaccines, and asked the French pharmaceutical giant to pay for testing on inoculated individuals.
The Health department made the demand in a letter to Sanofi Pasteur Asia-Pacific head Thomas Triomphe, for all unused vials of anti-dengue vaccine Dengvaxia worth P1.4 billion or $27.8 million.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.